Cite
HARVARD Citation
Li, X. et al. (2022). Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial. Journal of clinical oncology. 40 (11), pp. 1163-1173. [Online].